Xue, F., Guo, S., Liu, P., Chen, W., Chen, Y., Wen, Q., Hua, H., Cao, Y., Feng, X., Sun, J., Xu, C. and Yang, R. (2025) “First-in-human pharmacokinetic, safety, and preliminary efficacy studies of single- and multiple-dose FRSW117, a novel PEGylated recombinant factor VIII-Fc fusion protein with an extended half-life, in patients with severe hemophilia A”, Haematologica. Pavia, Italy, 110(11), pp. 2786-2791. doi: 10.3324/haematol.2024.286964.